Ambagon Therapeutics
www.ambagontx.comAmbagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins. Ambagon’s platform approach will open opportunities to address major unmet clinical needs beyond oncology.
Read more
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins. Ambagon’s platform approach will open opportunities to address major unmet clinical needs beyond oncology.
Read more
Country
State
California
City (Headquarters)
San Francisco
Industry
Employees
11-50
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President Finance
Email ****** @****.comPhone (***) ****-****Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Senior Director
Email ****** @****.comPhone (***) ****-****
Technologies
(32)
Reach decision makers at Ambagon Therapeutics
Free credits every month!
Ambagon Therapeutics FAQ
San Francisco, United States
Biotechnology Research
